BD Acquires MedKeeper to Be offering Cloud-based, Attached Pharmacy Tool

MedKeeper’s platform will turn into a part of the corporate’s present portfolio of hooked up drugs control functions. Through combining MedKeeper’s platform with BD’s wide generation experience, the corporations will paintings to optimize the preparation of compounded medicines – a essential want within the pharmacy lately.

“Making ready the proper dose for sufferers calls for a mixture of things – together with staff, coaching, and compliance. Pharmacy leaders require IV workflow control generation this is customized to their wishes and works inside their atmosphere,” mentioned Mike Garrison, International President of Drugs Control Answers at BD. “Including MedKeeper to our portfolio will allow us to supply our shoppers simple to make use of, customizable answers that make significant and incremental growth in IV workflow control.”

Lately, many pharmacies leverage a mixture of each guide and technical equipment for his or her IV workflow control gadget. Including MedKeeper to BD’s Drugs Control Answers portfolio will additional give a boost to the corporate’s talent to ship answers that absolute best meet shoppers’ wishes – now and at some point.

“Calls for in lately’s pharmacy atmosphere, reminiscent of COVID-impacted exertions shortages and converting regulatory necessities, have additional exacerbated the desire for customizable pharmacy tool answers to give a boost to versatile, directed workflow, stock monitoring and reporting wishes in sterile and non-sterile compounding,” mentioned Garrison. “Guide, time-consuming procedures that would possibly as soon as had been ‘excellent sufficient’ now may also be changed and augmented by means of tool that allows pharmacists to supply a better usual of care.”

BD and MedKeeper will paintings to supply shoppers with flexibility and functions in assembly business requirements for getting ready compounded medicines, incorporating the newest regulatory steering. In combination, the corporations are devoted to making sure that each and every buyer has a workflow answer that absolute best helps their atmosphere and delivers efficiencies to their frontline clinicians.

The transaction is predicted to be immaterial to BD’s fiscal 2022 monetary effects.

About BD
BD is among the greatest world clinical generation firms on the planet and is advancing the arena of well being™ by means of bettering clinical discovery, diagnostics and the supply of care. The corporate helps the heroes at the frontlines of well being care by means of creating leading edge generation, services and products and answers that lend a hand advance each scientific remedy for sufferers and scientific procedure for well being care suppliers. BD and its 70,000 workers have a zeal and dedication to lend a hand reinforce the security and potency of clinicians’ care supply procedure, allow laboratory scientists to correctly locate illness and advance researchers’ functions to expand the following technology of diagnostics and therapeutics. BD has a presence in nearly each and every nation and companions with organizations around the globe to deal with probably the most maximum difficult world well being problems. Through operating in shut collaboration with shoppers, BD can lend a hand reinforce results, decrease prices, building up efficiencies, enhance protection and make bigger get admission to to well being care. For more info on BD, please discuss with or connect to us on LinkedIn at and Twitter @BDandCo.

This press unencumber comprises positive estimates and different forward-looking statements (as outlined beneath Federal securities rules) in regards to the expected advantages of the purchase of MedKeeper. Ahead shopping statements normally are accompanied by means of phrases reminiscent of “will”, “be expecting”, or equivalent phrases, words or expressions. Those statements are in keeping with the present expectancies of BD control and are topic to a lot of dangers and uncertainties relating to MedKeeper’s industry and the purchase, and exact effects might range materially from any expected effects described, implied or projected in any forward-looking remark. Those dangers and uncertainties come with, however aren’t restricted to, dangers on the subject of the combination of MedKeeper’s generation, tool and workers into BD and the time and assets required to take action and the chance that the expected advantages of the purchase might not be discovered or might not be discovered throughout the anticipated time frame; aggressive components, together with the improvement of latest applied sciences by means of different firms and pricing and marketplace percentage pressures; adjustments in healthcare or different governmental law; dangers on the subject of the facility to care for favorable provider preparations and relationships; adjustments in regional, nationwide or international financial prerequisites, in addition to different components mentioned in BD’s filings with the Securities Trade Fee. BD does now not intend to replace any forward-looking statements to mirror occasions or cases after the date hereof, excluding as required by means of appropriate rules or rules.




Trey Hollern                                                                                                      

Francesca DeMartino

Director, Public Members of the family                                                                              

SVP, Head of Investor Members of the family



[email protected]                                                                                    

[email protected]    

SOURCE BD (Becton, Dickinson and Corporate)

BD Acquires MedKeeper to Be offering Cloud-based, Attached Pharmacy Tool